Abstract
G protein-coupled CB1 cannabinoid receptors are found in high density in the nervous system. CB1 cannabinoid receptors have the ability to change conformation between inactive and active receptor states in the absence of agonists. The ability to adopt an active conformation in the absence of agonists results in constitutive receptor signaling. Inverse agonists reverse the constitutive activity of the receptor in the absence of agonists also antagonize receptor activity due to the presence of agonists. This dual effect of the CB1 cannabinoid receptor inverse agonist SR141716A is a result of its ability to bind both inactive and active receptors, but with a relatively higher affinity for the inactive receptor. The higher affinity of SR141716A for the inactive receptor is due to its ability to hydrogen bond to lysine 3.28 in transmembrane helix 3, a residue available to SR141716A only in the inactive state.
Keywords: Protein-Coupling, transmembrane, SR141716A
Current Neuropharmacology
Title: Cannabinoid Receptor G Protein-Coupling and Inverse Agonism
Volume: 2 Issue: 1
Author(s): Deborah L. Lewis
Affiliation:
Keywords: Protein-Coupling, transmembrane, SR141716A
Abstract: G protein-coupled CB1 cannabinoid receptors are found in high density in the nervous system. CB1 cannabinoid receptors have the ability to change conformation between inactive and active receptor states in the absence of agonists. The ability to adopt an active conformation in the absence of agonists results in constitutive receptor signaling. Inverse agonists reverse the constitutive activity of the receptor in the absence of agonists also antagonize receptor activity due to the presence of agonists. This dual effect of the CB1 cannabinoid receptor inverse agonist SR141716A is a result of its ability to bind both inactive and active receptors, but with a relatively higher affinity for the inactive receptor. The higher affinity of SR141716A for the inactive receptor is due to its ability to hydrogen bond to lysine 3.28 in transmembrane helix 3, a residue available to SR141716A only in the inactive state.
Export Options
About this article
Cite this article as:
Lewis L. Deborah, Cannabinoid Receptor G Protein-Coupling and Inverse Agonism, Current Neuropharmacology 2004; 2 (1) . https://dx.doi.org/10.2174/1570159043476891
DOI https://dx.doi.org/10.2174/1570159043476891 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges
Current Neuropharmacology Melatonin Synthetic Analogs as Nitric Oxide Synthase Inhibitors
Mini-Reviews in Medicinal Chemistry Cerebral White Matter Injuries Following a Hypoxic/Ischemic Insult During the Perinatal Period: Pathophysiology, Prognostic Factors, and Future Strategy of Treatment Approach. A Minireview
Current Pharmaceutical Design Exercise-Induced Overexpression of Angiogenic Factors and Reduction of Ischemia / Reperfusion Injury in Stroke
Current Neurovascular Research Recombinant Antibody Fragments for Neurodegenerative Diseases
Current Neuropharmacology The Role of N-Methyl-D-Aspartate Receptor - Mediated Neurotransmission in Attention Deficit (Hyperactivity) Disorder (ADHD/ADD)
Current Psychopharmacology Selegiline (l-Deprenyl) as a Unique Neuroprotective Agent for Chronic Neurodegenerative Disorders- A Lesson from MAO Inhibition
Current Medicinal Chemistry - Central Nervous System Agents The Dynamic TRPA1 Channel: A Suitable Pharmacological Pain Target?
Current Pharmaceutical Biotechnology The Function and Regulation of BMP6 in Various Kinds of Stem Cells
Current Pharmaceutical Design CB1 Cannabinoid Receptors and their Associated Proteins
Current Medicinal Chemistry Perinatal Brain Injury
Current Pediatric Reviews Different Treatment Strategies for Pediatric Brain Tumors
Current Pediatric Reviews Stem Cells: In Sickness and in Health
Current Stem Cell Research & Therapy Insulin-Like Growth Factor 2 - The Oncogene and its Accomplices
Current Pharmaceutical Design Persistent Current Blockers of Voltage-Gated Sodium Channels: A Clinical Opportunity for Controlling Metastatic Disease
Recent Patents on Anti-Cancer Drug Discovery Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
Current Genomics Polyglutamine Protein Trafficking and Neurodegeneration
Current Genomics Imaging of Wallerian Degeneration in the Brain
Current Medical Imaging The Na+/Ca2+ Exchanger Mediates the Effects of Oxidative Stress in Hypertension
Current Hypertension Reviews Neuroimaging of the Serotonin Transporter: Possibilities and Pitfalls
Current Psychiatry Reviews